Lyell Wealth Management LP Purchases 1,171 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Lyell Wealth Management LP increased its stake in Intuitive Surgical, Inc. by 3.4% during the second quarter, bringing its total holdings to 35,658 shares valued at approximately $19.4 million.
• Insider Myriam Curet sold 4,500 shares of Intuitive Surgical, significantly reducing her position by 92.73%, while another insider, Gary S. Guthart, sold 29,360 shares decreasing his ownership by 59.69%.
• Intuitive Surgical reported earnings of $2.19 per share for the last quarter, exceeding analysts' expectations, and its stock has a consensus rating of "Moderate Buy" from analysts with an average target price of $580.29.

Lyell Wealth Management LP increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,658 shares of the medical equipment provider's stock after purchasing an additional 1,171 shares during the quarter. Intuitive Surgical makes up approximately 1.5% of Lyell Wealth Management LP's holdings, making the stock its 15th largest holding. Lyell Wealth Management LP's holdings in Intuitive Surgical were worth $19,377,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the first quarter worth $26,000. LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical in the first quarter valued at $30,000. TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the 1st quarter valued at $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In related news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $446.13 on Monday. The firm has a 50 day moving average price of $454.97 and a 200-day moving average price of $495.76. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market capitalization of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ISRG shares. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Truist Financial decreased their price target on shares of Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating for the company in a research note on Wednesday, October 15th. The Goldman Sachs Group lowered their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating for the company in a report on Wednesday, October 1st. Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating on the stock in a report on Tuesday, October 7th. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday. Fourteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $580.29.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.